Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats

Circulation Journal

Volumn 69, Issue 11, 2005, Pages 1418-1424

  Xiaohui, Li ^a   Junbao, Du ^a   Lin, Shi ^a   Jian, Li ^a   Xiuying, Tang ^a   Jianguang, Qi ^a   Bing, Wei ^a   Hongfang, Jin ^a   Chaoshu, Tang ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

High pulmonary blood flow; Hydrogen sulfide; Pulmonary hypertension; Pulmonary vascular structural remodeling

Indexed keywords

CYSTATHIONINE BETA LYASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; IN SITU HYBRIDIZATION; LUNG BLOOD FLOW; LUNG BLOOD VESSEL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOOD FLOW VELOCITY; DOWN-REGULATION; HYDROGEN SULFIDE; HYPERTENSION, PULMONARY; LUNG; MALE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 27644492323     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1418     Document Type: Article

References (26)

1. Wei B, Du JB, Qi JG, Li J, Tang CS. L-Arginine impacts pulmonary vascular structure in rats with an aortocaval shunt. J Surg Res 2002; 108: 20-31.
2. Campbell AI, Kuliszewski MA, Stewart DJ. Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. Am J Respir Cell Mol Biol 1999; 21: 567-575.
3. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, et al. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000; 86: 1224-1229.
4. Kourembanas S. Hypoxia and carbon monoxide in the vasculature. Antioxidant Redox Signal 2002; 4: 291-299.
5. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, et al. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Ntl Acad Sci USA 2001; 98: 8798-8803.
6. Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 2002; 26: 13-19.
7. Zhao W, Wang R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 2002; 283: H474- H480.
8. Dombkowski RA, Russell MJ, Olson KR. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 2004; 286: R678- R685.
9. Du JB, Yan H, Zhang ChY, Geng B, Jiang H, Ch XB, et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19: 75-80.
10. Zhang CY, Du JB, Bu DF, Yan H, Tang XY, Tang CS. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-816.
11. Garcia R, Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 1990; 24: 430-432.
12. Barth PJ, Kimpel C, Roy S, Wagner U. An improved mathematical approach for the assessment of the medial thickness of pulmonary arteries. Pathol Res Pract 1993; 189: 567-576.
13. Siebert PD, Larrick JW. Competitive PCR. Nature 1992; 395: 557-558.
14. Sambrook J, Russell DW. Molecular cloning: A laboratory manual, 3rd edn, Vol. 2. Cold Spring Harbor Laboratory Press; 2001; 8.86-8.89.
15. Egito ES, Aiello VD, Bosisio IB, Lichtenfels AJ, Horta AL, Saldiva PH, et al. Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease. Pathol Res Pract 2003; 199: 521-532.
16. Granton JT, Rabinovitch M. Pulmonary arterial hypertension in congenital heart disease Cardiol Clin 2002; 20: 441-457.
17. Vachharajani TJ, Work J, Issekutz AC, Granger DN. Heme oxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol 2000; 278: H1613- H1617.
18. Qi J, Du J, Tang X, Li J, Wei B, Tang C. The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart Vessels 2004, 19: 81-88.
19. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527-531.
20. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066-1071.
21. Du JB, Chen XB, Geng B, Jiang HF, Tang CS. Hydrogen sulfide as a messenger molecule in cardiovascular system. J Peking University (Health Sci) 2002; 34: 187.
22. Fujii K, Sakuragawa T, Kashiba M, Sugiura Y, Kondo M, Maruyama K, et al. Hydrogen sulfide as an endogenous modulator of biliary bicarbonate excretion in the rat liver. Antioxidant Redox Signal 2005; 7: 788-794.
23. Wang R. Two's company, three's a crowd: Can H2S be the third endogenous gaseous transmitter? FASEB J 2002; 16: 1792-1798.
24. Kimura H, Nagai Y, Umemura K, Kimura Y. Physiological roles of hydrogen sulfide: Synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxidant Redox Signal 2005; 7: 795-803.
25. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 2001; 20: 6008-6016.
26. Yan H, Du JB, Tang CS. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004; 313: 22-27.